Introduction
Pemphigus vulgaris is a chronic autoimmune blistering disorder in which the immune system targets proteins that hold skin cells and mucosal epithelial cells together. The result is loss of adhesion between cells in the outer layers of the skin and the lining of the mouth and, in some cases, other mucosal surfaces. At a biological level, the condition is defined by antibodies directed against desmosomal adhesion molecules, especially desmoglein 3 and, in many cases, desmoglein 1. When these adhesion systems are disrupted, the tissue splits within the epithelium and fragile blisters form.
The disease primarily involves stratified squamous epithelium, the type of tissue that makes up the epidermis and many mucosal linings. Unlike disorders caused by infection or direct injury, pemphigus vulgaris develops because of a misdirected immune response that interferes with normal cell-to-cell attachment. Understanding this mechanism is the key to understanding the condition itself.
The Body Structures or Systems Involved
The main structures affected by pemphigus vulgaris are the epidermis and mucous membranes, particularly the oral mucosa. These tissues are lined by keratinocytes, which are epithelial cells arranged in layers and held together by specialized junctions called desmosomes. Desmosomes act as mechanical fastening points, allowing the tissue to resist friction, stretching, and everyday wear.
Desmosomes contain several proteins, but in pemphigus vulgaris the most important targets are the cadherin proteins desmoglein 3 and desmoglein 1. These proteins span the cell membrane and connect neighboring keratinocytes through calcium-dependent adhesion. In healthy tissue, they help maintain the integrity of the epithelium so that the surface remains intact under mechanical stress.
The immune system is also central to the disorder. B lymphocytes produce autoantibodies, and T-cell help contributes to the autoimmune response. In this setting, the immune system no longer distinguishes a normal epithelial adhesion protein from a foreign target. The disorder is therefore not limited to one organ in the usual sense; it is an immune-mediated disease of epithelial adhesion.
How the Condition Develops
Pemphigus vulgaris develops when the adaptive immune system generates antibodies against desmogleins, most often IgG autoantibodies. These antibodies bind to the extracellular portion of desmoglein molecules on keratinocytes. Once bound, they interfere with adhesion in several ways. They can block the normal interaction between desmogleins, alter their distribution on the cell surface, and trigger internalization or removal of these proteins from desmosomes.
The loss of desmoglein function weakens desmosomes and disrupts acanthocyte adhesion, a process known as acantholysis. When keratinocytes no longer adhere tightly to one another, the epithelial sheet separates within its own thickness. This creates an intraepithelial cleft, which later fills with fluid and appears clinically as a blister. Because the split occurs above the basal layer in pemphigus vulgaris, the blister wall is thin and fragile.
The body’s immune mechanisms amplify the process. Autoantibody binding can activate signaling pathways inside keratinocytes, including pathways involving calcium influx, protein kinases, and cytoskeletal rearrangement. These intracellular changes make the cells less able to maintain attachment even before the physical structure of the desmosome is completely lost. Complement may also participate in some cases, but pemphigus vulgaris is not primarily a classic complement-driven disease. The core mechanism is antibody-mediated disruption of epithelial cohesion.
Why the mouth is often affected early relates to desmoglein distribution. Oral mucosa relies heavily on desmoglein 3 for adhesion, whereas the skin uses both desmoglein 3 and desmoglein 1 in different layers. When antibodies target desmoglein 3, the mucosa may lose cohesion before the skin does. If antibodies also target desmoglein 1, skin involvement becomes more prominent.
Structural or Functional Changes Caused by the Condition
The most characteristic structural change is suprabasal acantholysis, meaning the separation of keratinocytes just above the basal cell layer. Basal cells often remain attached to the basement membrane through hemidesmosomes, creating the classic microscopic appearance sometimes described as a row of cells still anchored at the base. Above that layer, the epithelium detaches and forms a cavity.
This structural breakdown has several functional consequences. The epithelial barrier becomes mechanically fragile, so minor friction or normal movement can produce new lesions. Because the outer layer is no longer continuous, the tissue loses some of its ability to protect underlying structures from desiccation, microbial entry, and physical trauma. In mucosal surfaces, where moisture and motion are constant, this loss of cohesion is particularly disruptive.
Inflammation is usually present but is not the primary driver of tissue separation. The key event is immune-mediated weakening of cell adhesion. That distinction matters because the lesions are produced by structural failure at the cellular junction level rather than by primary tissue destruction or necrosis. The epithelium does not simply die; it comes apart because the adhesive system that holds it together is altered.
At a broader physiological level, repeated epithelial breakdown can disturb the barrier function of skin and mucosa. The body then has to repair damaged surfaces, which involves cell migration, proliferation, and re-epithelialization. In chronic disease, ongoing autoantibody activity means that repair and damage may occur simultaneously.
Factors That Influence the Development of the Condition
Pemphigus vulgaris arises from an interaction between genetic susceptibility and immune dysregulation. Certain HLA class II alleles, especially within the HLA-DR and HLA-DQ regions, are associated with higher risk. These alleles influence how antigen fragments are presented to T cells, which can affect whether the immune system mounts a response against desmoglein peptides. Genetic predisposition does not cause the disease by itself, but it creates a background in which loss of tolerance is more likely.
Immune regulation is another major factor. Under normal conditions, central and peripheral tolerance mechanisms eliminate or suppress autoreactive lymphocytes. In pemphigus vulgaris, these controls fail to fully prevent activation of B cells and helper T cells that recognize epithelial adhesion proteins. Once that happens, antibody production can persist through memory B-cell and plasma-cell activity.
Environmental influences may contribute as triggers in susceptible individuals. Some drugs and infections have been associated with pemphigus-like immune activation, although the exact pathways vary and are not always fully defined. The common feature is immune stimulation or antigenic change that may help break tolerance. Hormonal influences and general inflammatory states may also affect immune reactivity, but they are not the primary mechanism.
The density and function of desmoglein proteins in different tissues also influence disease expression. This is not a risk factor in the usual sense, but it helps explain why some patients develop predominantly oral disease while others develop both oral and cutaneous lesions. The tissue-specific pattern depends on which adhesion proteins are most important in the affected epithelium and which autoantibodies are present.
Variations or Forms of the Condition
Pemphigus vulgaris is often described as having a mucosal-dominant form and a mucocutaneous form. In mucosal-dominant disease, autoantibodies mainly target desmoglein 3, so lesions are concentrated on surfaces such as the oral cavity. In mucocutaneous disease, antibodies also target desmoglein 1, allowing skin involvement as well. These patterns reflect the distribution of desmogleins in different epithelial layers rather than separate diseases.
The condition also varies in extent and intensity. Some individuals develop relatively limited erosions in one anatomic region, while others have widespread epithelial fragility affecting multiple mucosal surfaces and large areas of skin. This variation often corresponds to differences in autoantibody profile, titer, and the balance between pathogenic antibodies and compensatory adhesion mechanisms.
Another useful distinction is between active blister formation and the erosive phase that follows rupture. Because the blisters are fragile, intact blisters may be brief, and the visible lesions can quickly become erosions. The underlying pathology remains the same: loss of desmosomal adhesion leading to intraepithelial separation. The outward appearance changes according to how long the roof of the blister remains intact and how much mechanical stress the tissue experiences.
How the Condition Affects the Body Over Time
If pemphigus vulgaris persists, ongoing autoantibody production can maintain epithelial injury over long periods. The body may attempt repeated repair, but repair is complicated by continuing immune attack. This creates a cycle in which adhesion is lost, tissue splits, and the epithelium tries to regenerate while the autoimmune process remains active.
Chronic epithelial damage can alter the structure of affected tissues. Repeated cycles of detachment and healing may lead to persistent erosions, scarring in certain settings, and changes in local barrier function. In the skin and mucosa, the long-term issue is not only the presence of lesions but the breakdown of a protective surface that normally separates the body from the external environment.
In severe or prolonged disease, loss of barrier integrity can have systemic consequences. Damaged mucosa can interfere with feeding and hydration, and extensive skin involvement can increase fluid loss and susceptibility to secondary infection. These effects are downstream consequences of the primary epithelial defect. The disease begins as a molecular problem at the desmosome and can end up affecting overall physiological stability when enough surface area is involved.
Over time, immune memory can also reinforce the disorder. Autoreactive B cells and long-lived plasma cells may continue to produce antibodies unless the immune response is altered. This persistence helps explain why pemphigus vulgaris is often chronic rather than self-limited. The body has not simply suffered a one-time injury; it has developed an enduring autoimmune program directed at an essential structural protein.
Conclusion
Pemphigus vulgaris is an autoimmune disease of epithelial adhesion caused by antibodies against desmoglein proteins in desmosomes. It primarily affects the skin and mucous membranes, especially the oral lining, by weakening the junctions that hold keratinocytes together. The key biological event is acantholysis, which produces intraepithelial splitting and fragile blisters or erosions.
Its development reflects a failure of immune tolerance, the production of pathogenic IgG autoantibodies, and disruption of normal desmosomal function. The result is a barrier disorder at the cellular level, not a disease of simple inflammation or infection. Understanding the tissue structures involved and the antibody-mediated mechanism clarifies why the condition behaves as it does, why it tends to recur, and why its manifestations follow the distribution of desmoglein proteins in the body.